Tetrahydrobiopterin induces proteasome inhibitor resistance and tumor progression in multiple myeloma

Multiple myeloma (MM) still remains an incurable disease due to widespread drug resistance and high frequency of relapse. In this study, we found that tetrahydrobiopterin (BH4) promotes MM cell proliferation and tumor growth in vivo. BH4 also increases MM bortezomib (Bor) resistance in vitro and in...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Hua, Chen, Jintong, Zhang, Mingyue, Zhao, Munan, Zhang, Luyao, Liu, Bin, Wang, Siqing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2022
Materias:
Original Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8840911/
https://www.ncbi.nlm.nih.gov/pubmed/35150316
http://dx.doi.org/10.1007/s12032-021-01632-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8840911/
https://www.ncbi.nlm.nih.gov/pubmed/35150316
http://dx.doi.org/10.1007/s12032-021-01632-5

Ejemplares similares